Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of sodium oxybate (Xyrem) on endocrine changes in adult narcolepsy patients with cataplexy
2005-004417-15Phase 4Completed
- Sponsor
- UCB
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of sodium oxybate in narcolepsy type 1 (NT1), sponsored by UCB. Primary endpoint: IGF-1 level. Started Apr 2006; status: completed.
02
Drugs
sodium oxybate
03
Conditions
narcolepsy type 1 (NT1)
Beyond the preview
Go deeper on 2005-004417-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004417-15.